Browse
Browse and Search
Search
Explore more content
pmed.1003664.s002.
docx
(20.51 kB)
File info
This item contains files with download restrictions
Fullscreen
Search terms.
Cite
Download
(20.51 kB)
Share
Embed
journal contribution
posted on 2021-06-10, 17:40
authored by
Natan Pereira Gosmann
,
Marianna de Abreu Costa
,
Marianna de Barros Jaeger
,
Luis Souza Motta
,
Júlia Frozi
,
Lucas Spanemberg
,
Gisele Gus Manfro
,
Pim Cuijpers
,
Daniel Samuel Pine
,
Giovanni Abrahão Salum
(DOCX)
History
Usage metrics
Categories
Medicine
Science Policy
Mental Health
Keywords
three-level network meta-analysis
treatment discontinuation rate
acceptability
3- level approach
PROSPERO
Selective serotonin reuptake inhibitors
assessment instrument
disorder
symptom domains
norepinephrine reuptake inhibitors
CRD
internalizing symptoms
469 outcome measures
3- level network meta-analysis
SMD
serotonin reuptake inhibitors
CI
efficacy
SNRI
bias
medication
SSRI
3- level network meta-analysis Back...
MEDLINE
participant
11 November 2020.
Licence
CC BY 4.0
Exports
Select an option
RefWorks
RefWorks
BibTeX
BibTeX
Ref. manager
Ref. manager
Endnote
Endnote
DataCite
DataCite
NLM
NLM
DC
DC